Pharmacists in Saint George, SC Accepting Medicare
7 Pharmacists found. Showing 1 - 7
 Dr. Christina Michelle Orosz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 701 N Parler Ave, Saint George, SC 29477 Phone: 843-563-9384 |
 Mutahir Niaz Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5742 Memorial Blvd, Saint George, SC 29477 Phone: 843-563-2208 |
Mrs. Marla Ann Bilton-westbury, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 701 N Parler Ave, Saint George, SC 29477 Phone: 843-563-9384 |
Dr. Syldra Stephanie Stephens, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5742 Memorial Blvd, Saint George, SC 29477 Phone: 843-563-2208 |
James Lerow Hodges, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 204 N Parler Ave # North, Saint George, SC 29477 Phone: 843-563-3034 Fax: 843-563-3035 |
Brittany Sanders Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 701 N Parler Ave, Saint George, SC 29477 Phone: 843-563-9384 |
Amy L Sherman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5742 Memorial Blvd, Saint George, SC 29477 Phone: 843-563-2208 |
News Archive
No need to reduce red meat or processed meat intake, study claims
A study has revealed that humans do not need to reduce red meat or processed meat intake at the current levels.
A combination of chemotherapy drugs could double survival rates for pancreatic cancer
Pancreatic cancer has a poor prognosis. More than 80% of patients present with advanced disease at diagnosis, and mortality is high. A single chemotherapy drug, gemcitabine, is regarded as the standard treatment, but it has lead to a 1-year overall survival of only 17—28% in clinical trials.
Anadys Pharmaceuticals' ANA598 combination demonstrates 73% cEVR in ongoing Phase II study for HCV
Anadys Pharmaceuticals, Inc. today announced preliminary results from an ongoing Phase II study demonstrating that 73% of hepatitis C patients treated with 200 mg ANA598 twice daily in combination with pegylated interferon and ribavirin (SOC) achieved undetectable levels of virus (<15 IU/mL) at week 12, known as complete Early Virological Response or cEVR.
FDA approves Topigen's investigational New Drug Application for new inhalation drug to treat asthma
Phase 1 clinical trial can be initiated for ASM8, a new inhalation drug that is designed to treat asthma through a unique approach by attacking multiple mediators of the inflammatory mechanism rather than the single mediator approach of current therapies.
Specific dietary guidelines may help people with bipolar disorders to better manage their health
Can specific dietary guidelines help people living with bipolar disorders better manage their health? Maybe someday, according to a new study by Penn State College of Medicine researchers. Clinical trial results showed that a diet designed to alter levels of specific fatty acids consumed by participants may help patients have less variability in their mood.
› Verified 3 days ago